1,289
Views
23
CrossRef citations to date
0
Altmetric
Research Papers

HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy

, , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Satyavani Kaliamurthi, Gurudeeban Selvaraj, Aman Chandra Kaushik, Ke-Ren Gu & Dong-Qing Wei. (2018) Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus. Biologics: Targets and Therapy 12, pages 107-125.
Read now
Marcelo Nazário Cordeiro, Rita de Cássia Pereira De Lima, Francesca Paolini, Alanne Rayssa da Silva Melo, Ana Paula Ferreira Campos, Aldo Venuti & Antonio Carlos De Freitas. (2018) Current research into novel therapeutic vaccines against cervical cancer. Expert Review of Anticancer Therapy 18:4, pages 365-376.
Read now

Articles from other publishers (21)

Biqing Chen, Liping Zhao, Rulin Yang & Tianmin Xu. (2023) Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis. Archives of Biochemistry and Biophysics 745, pages 109716.
Crossref
Alexandre Santos Matos, Maria da Conceição Viana Invenção, Ingrid Andrêssa de Moura, Antonio Carlos de Freitas & Marcus Vinicius de Aragão Batista. (2023) Immunoinformatics applications in the development of therapeutic vaccines against human papillomavirus‐related infections and cervical cancer. Reviews in Medical Virology.
Crossref
Nabil F. Saba, Saagar Pamulapati, Bhamini Patel, Mayur Mody, Primož Strojan, Robert Takes, Antti A. Mäkitie, Oded Cohen, Pia Pace-Asciak, Jan B. Vermorken, Carol Bradford, Arlene Forastiere, Yong Teng, Andreas Wieland & Alfio Ferlito. (2023) Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer. Cancers 15:7, pages 1959.
Crossref
Ingrid Andrêssa de Moura, Anna Jéssica Duarte Silva, Larissa Silva de Macêdo, Maria da Conceição Viana Invenção, Mylenna Máyra Gois de Sousa & Antonio Carlos de Freitas. (2022) Enhancing the Effect of Nucleic Acid Vaccines in the Treatment of HPV-Related Cancers: An Overview of Delivery Systems. Pathogens 11:12, pages 1444.
Crossref
Grégoire B. Morand, Isabel Cardona, Sara Brito Silva Costa Cruz, Alex M. Mlynarek, Michael P. Hier, Moulay A. Alaoui-Jamali & Sabrina Daniela da Silva. (2022) Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?. International Journal of Molecular Sciences 23:15, pages 8395.
Crossref
Parisa Shiri Aghbash, Milad Shirvaliloo, Ammar Khalo Abass Kasho, Farbod Alinezhad, Hans Nauwynck & Hossein Bannazadeh Baghi. (2022) Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?. International Immunopharmacology 108, pages 108896.
Crossref
Yaxuan Huang, Yunyun Lan, Zhe Zhang, Xue Xiao & Tingting Huang. (2022) An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma. Frontiers in Oncology 12.
Crossref
Francesca Paolini, Carla Amici, Mariantonia Carosi, Claudia Bonomo, Paola Di Bonito, Aldo Venuti & Luisa Accardi. (2021) Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Siobhan Gargan & Nigel J. Stevenson. (2021) Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease. Viruses 13:11, pages 2165.
Crossref
Danilo Ranieri, Deborah French, Salvatore Raffa, Luisa Guttieri, Maria Rosaria Torrisi & Francesca Belleudi. (2021) Expression of the E5 Oncoprotein of HPV16 Impacts on the Molecular Profiles of EMT-Related and Differentiation Genes in Ectocervical Low-Grade Lesions. International Journal of Molecular Sciences 22:12, pages 6534.
Crossref
Oscar Badillo-Godinez, Adolfo Pedroza-Saavedra, Veronica Valverde-Garduño, Victor Bermudez-Morales, Minerva Maldonado-Gama, Ricardo Leon-Letelier, Laura C. Bonifaz, Fernando Esquivel-Guadarrama & Lourdes Gutierrez-Xicotencatl. (2021) Induction of Therapeutic Protection in an HPV16-Associated Mouse Tumor Model Through Targeting the Human Papillomavirus-16 E5 Protein to Dendritic Cells. Frontiers in Immunology 12.
Crossref
Lourdes Gutierrez-Xicotencatl, Adolfo Pedroza-Saavedra, Lilia Chihu-Amparan, Azucena Salazar-Piña, Minerva Maldonado-Gama & Fernando Esquivel-Guadarrama. (2021) Cellular Functions of HPV16 E5 Oncoprotein during Oncogenic Transformation. Molecular Cancer Research 19:2, pages 167-179.
Crossref
Adrian von Witzleben, Eve Currall, Oliver Wood, Lindsey Chudley, Oluyemisi Akinyegun, Jaya Thomas, Kaïdre Bendjama, Gareth J. Thomas, Peter S. Friedmann, Emma V. King, Simon Laban & Christian H. Ottensmeier. (2021) Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC. Frontiers in Oncology 10.
Crossref
Zhen Dong, Renjian Hu, Yan Du, Li Tan, Lin Li, Juan Du, Longchang Bai, Yingkang Ma & Hongjuan Cui. (2021) Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers. Frontiers in Immunology 11.
Crossref
Amit Kumar Gupta & Manoj Kumar. (2020) HPVomics: An integrated resource for the human papillomavirus epitome and therapeutics. Genomics 112:6, pages 4853-4862.
Crossref
Adrian von Witzleben, Chuan Wang, Simon Laban, Natalia Savelyeva & Christian H. Ottensmeier. (2020) HNSCC: Tumour Antigens and Their Targeting by Immunotherapy. Cells 9:9, pages 2103.
Crossref
Heidar Ali Panahi, Azam Bolhassani, Gholamreza Javadi, Zahra Noormohammadi & Elnaz Agi. (2020) Development of multiepitope therapeutic vaccines against the most prevalent high-risk human papillomaviruses. Immunotherapy 12:7, pages 459-479.
Crossref
Gemma Hancock, Joshua Blight, Cesar Lopez-Camacho, Jakub Kopycinski, Mamatha Pocock, Wendy Byrne, Michael J. Price, Phillip Kemlo, Ranoromanana Ionitiana Evans, Angela Bloss, Kathryn Saunders, Richard Kirton, Monique Andersson, Karin Hellner, Arturo Reyes-Sandoval & Lucy Dorrell. (2019) A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins. Scientific Reports 9:1.
Crossref
Chuan Wang, James Dickie, Ruhcha V. Sutavani, Catherine Pointer, Gareth J. Thomas & Natalia Savelyeva. (2018) Targeting Head and Neck Cancer by Vaccination. Frontiers in Immunology 9.
Crossref
Alexander Y. Deneka, Jeffrey C. Liu & Camille C. R. Ragin. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer 545 583 .
Antonio Carlos de Freitas, Talita Helena Araújo de Oliveira, Marconi Rego BarrosJr.Jr. & Aldo Venuti. (2017) hrHPV E5 oncoprotein: immune evasion and related immunotherapies. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.